Bibliografía
1- Primary prevention of CVD: treating dyslipidaemia. BM Clin evidence2008; 02:215.
2- "Accidente Cerebrovascular: Esperanza en la Investigación", NINDS. Julio 2008
3- Fadini GP, de Kreutzenberg SV, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J. 2006 Sep; 27(18):2247-55.
4- Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004; 291:47-53.
5- Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352:20-28.
6- Querzhi A, Sofodar K, Patel M, Janasen RS, Frankel MR. Stroke in young black patients.Risk factors subtypes and prognosis.Stroke.2005, (26)
7- Álvarez-Aliaga A, Liuska Haydée Rodríguez-Blanco LH, Quesada-Vázquez AJ, López Costa C. Factores de riesgo de la enfermedad cerebrovascular aguda hipertensiva. Rev Cubana Med 2006; 45(4).
8- Laura Sundell L, Salomaa V, Vartiainen E, Poikolainen K, Laatikainen T. Increased Stroke Risk Is Related to a Binge Drinking Habit. Published Onlineon October 2, 2008.
9- Beckett N et al. The HYVET study group.Treatment of Hypertension in Patients 80 Years of Age or Older. NEJM, May 2008; 358 (18):1887-1898.
10-Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004; 35:1024-1024.
11-Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1749
12-Oates DJ, Berlowitz DR, Glickman ME, Silliman RA, Borzecki AM. Blood pressure and survival in the oldest old. J Am Geriatr Soc 2007; 55:383-388.
13-Fernández-Britto JE, Carlevario PV. Sistema aterométrico: Conjunto de métodos y procedimientos para la caracterización de la lesión aterosclerótica. Base científica. Clin Invest Arteriosclerosis 1998; 10 (3): 148-53.
14-Fernández-Britto JE, Bacallao J, Wong R, Campos R, Guski H. Impacto de la diabetes y la hipertensión en la aterosclerosis cerebral, coronaria e íleo-femoral: Estudio patomorfológico y morfométrico usando el sistema aterométrico. Bol Inform SOLAT 1994; 4 (8): 3-11.
15-Zuliani G, Cherubini A, Ranzini M, Ruggiero C, Atti AR, Fellin R. Risk factors for short-term mortality in older subjects with acute ischemic stroke. Gerontology 2006; 52:231-236.
16-Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB et al. Trends in Incidence, Lifetime Risk, Severity, and 30-Day Mortality of Stroke Over the Past 50 Years. JAMA. 2006; 296:2939-2946.
17-Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension: the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350:757-764.
|